Skip to content

Exploration of the application value and safety of Cycloidal Vibration in patients with pulmonary infection after thoracotomy in the cardiac surgery intensive care unit

Exploration of the application value and safety of Cycloidal Vibration in patients with pulmonary infection after thoracotomy in the cardiac surgery intensive care unit

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110742
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary infection after cardiac surgery

Interventions

Intervention group :On the basis of the standard treatment in the control group, during the period in the intensive care unit, three-dimensional vibration expectoration treatment was carried out using
control group:A multidisciplinary team composed of doctors, nurses and physiotherapists provides standard anti-infection treatment for the lungs and routine care, including the use of antibiotics, oxy

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of pulmonary infection: Pneumonia is defined as the presence of new or progressive pulmonary infiltration and two of the following: body temperature >38.3°C or 12,000 cells /mL or < 4,000 cells /mL; Purulent airway discharge; There are no other signs of infection that require antibacterial treatment. 2.Age: 18-75 years old; 3.The Acute Physiology and Chronic Health Assessment (APACHE-II) score is 15 to 40 points; 4.Voluntarily participate in the research and obtain informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnancy; 2. Pneumothorax or daily drainage volume exceeding 300mL; 3. Rib fractures or skin damage in the treatment area; 4.Obvious hemoptysis; 5.Hemodynamic instability (i.e., despite active fluid resuscitation, systolic blood pressure 40 mmHg, or mean arterial blood pressure <60 mmHg); 6. Increased intracranial pressure; 7.Any other serious medical conditions that cannot pass the safety assessment: such as severe organ failure, severe malignant arrhythmia, etc.

Design outcomes

Primary

MeasureTime frame
Therapeutic effect of Pulmonary infection;

Secondary

MeasureTime frame
The duration of lung infection controlled;Mechanical ventilation duration;Length of stay in the ICU;

Countries

China

Contacts

Public ContactPengming YU

West China Hospital of Sichuan University

13438201451@126.com+86 134 3820 1451

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026